Literature DB >> 3635466

Complement activation in septic shock patients.

C L Sprung, D R Schultz, E Marcial, P V Caralis, M A Gelbard, P I Arnold, W M Long.   

Abstract

To evaluate the status of the complement system and to determine the effects of corticosteroids on complement component levels in septic shock, C3, C4, and Factor B were measured in 42 patients with severe late septic shock. Serum levels of C4 and Factor B correlated with C3 levels (r = 0.48 and 0.64, respectively; p less than .01) in patients in shock for more than 4 h, but only Factor B correlated with C3 (r = 0.85; p less than .01) in patients in shock for 4 h or less. C3 and Factor B levels were significantly (p less than .05) lower in patients who died (12,174 +/- 1,524 CH50 U/ml and 14 +/- 1 mg/dl, respectively) than in patients who survived (18,418 +/- 2,833 CH50 U/ml and 21 +/- 2 mg/dl, respectively). Corticosteroids did not alter complement component levels. The alternative pathway appears to be activated early in septic shock, whereas the classical pathway is activated later. C3 and Factor B levels may predict survival of patients in septic shock. In this study, corticosteroids did not change the complement component levels of patients in late severe septic shock.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3635466     DOI: 10.1097/00003246-198606000-00001

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  Chronological changes in the complement system in sepsis.

Authors:  H Nakae; S Endo; K Inada; M Yoshida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.

Authors:  S Stöve; T Welte; T O Wagner; A Kola; A Klos; W Bautsch; J Köhl
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

3.  Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome.

Authors:  G Zilow; J A Sturm; U Rother; M Kirschfink
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

4.  New aspects in the treatment of gram-negative bacteraemia and septic shock.

Authors:  I Schedel
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 5.  The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective.

Authors:  C J Kirkpatrick; F Bittinger; C L Klein; S Hauptmann; B Klosterhalfen
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

Review 6.  [Causes and therapy of organ failure: mediators, their role and therapeutic implications as exemplified by the infected patient].

Authors:  H Neuhof
Journal:  Langenbecks Arch Chir       Date:  1987

Review 7.  Activated Complement Factors as Disease Markers for Sepsis.

Authors:  Jean Charchaflieh; Julie Rushbrook; Samrat Worah; Ming Zhang
Journal:  Dis Markers       Date:  2015-09-02       Impact factor: 3.434

Review 8.  Role of complement in multiorgan failure.

Authors:  Daniel Rittirsch; Heinz Redl; Markus Huber-Lang
Journal:  Clin Dev Immunol       Date:  2012-12-20

Review 9.  The role of complement system in septic shock.

Authors:  Jean Charchaflieh; Jiandong Wei; Georges Labaze; Yunfang Joan Hou; Benjamin Babarsh; Helen Stutz; Haekyung Lee; Samrat Worah; Ming Zhang
Journal:  Clin Dev Immunol       Date:  2012-09-23

10.  The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.

Authors:  Z M Quezado; W D Hoffman; J A Winkelstein; I Yatsiv; C A Koev; L C Cork; R J Elin; P Q Eichacker; C Natanson
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.